Using Dabigatran in Patients With Stroke A Practical Guide for Clinicians

被引：30
作者：
Alberts, Mark J. [1 ]
Bernstein, Richard A. [1 ]
Naccarelli, Gerald V. [2 ]
Garcia, David A. [3 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Penn State Heart & Vasc Inst, Hershey, PA USA
[3] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
来源：
STROKE | 2012年 / 43卷 / 01期
关键词：
antithrombotics; prevention; therapy; thrombosis; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ATRIAL-FIBRILLATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HEMORRHAGIC TRANSFORMATION; TASK-FORCE; WARFARIN; RISK; THERAPY;
D O I：
10.1161/STROKEAHA.111.622498
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：271 / 279
页数：9
相关论文
共 50 条
  • [1] Letter by Casado-Naranjo et al Regarding Article, "Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians"
    Casado-Naranjo, Ignacio
    Portilla-Cuenca, Juan Carlos
    Jimenez-Caballero, Pedro Enrique
    STROKE, 2012, 43 (05) : E45 - E45
  • [2] Dabigatran for the prevention of stroke in patients with atrial fibrillation
    Diener, Hans-Christoph
    Weber, Ralph
    Weimar, Christian
    Frank, Benedikt
    Kirchhof, Paulus
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (04): : 156 - +
  • [3] Stroke thrombolysis in patients taking dabigatran
    Jayathissa, S.
    Gommans, J.
    Harper, P.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (07) : 826 - 828
  • [4] Concentrations of dabigatran administered after acute ischemic stroke
    Wada, Shinichi
    Inoue, Manabu
    Matsuki, Takayuki
    Okata, Takuya
    Kumamoto, Masaya
    Tagawa, Naoki
    Yoshimura, Sohei
    Okamoto, Akira
    Miyata, Toshiyuki
    Ihara, Masafumi
    Toyoda, Kazunori
    Koga, Masatoshi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 411
  • [5] Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians
    Foody, Joanne M.
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 175 - 187
  • [6] Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study
    Grosse, Gerrit M.
    Weimar, Christian
    Kuklik, Nils
    Huesing, Anika
    Stang, Andreas
    Brinkmann, Marcus
    Eschenfelder, Christoph C.
    Diener, Hans-Christoph
    EUROPEAN STROKE JOURNAL, 2021, 6 (04) : 438 - 444
  • [7] Dabigatran for Stroke Prevention in Patients with TIA or Ischaemic Stroke and Atrial Fibrillation: Practical Apects
    Diener, H. C.
    Grond, M.
    Roether, J.
    Veltkamp, R.
    Weber, R.
    Weimar, C.
    Hohnloser, S. H.
    AKTUELLE NEUROLOGIE, 2011, 38 (05) : 261 - 266
  • [8] Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?
    Calvo Romero, J. M.
    REVISTA CLINICA ESPANOLA, 2011, 211 (03): : 142 - 146
  • [9] Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach
    Woock, Malin
    Martinez-Majander, Nicolas
    Seiffge, David J.
    Selvik, Henriette Aurora
    Nordanstig, Annika
    Redfors, Petra
    Lindgren, Erik
    Sanchez van Kammen, Mayte
    Rentzos, Alexandros
    Coutinho, Jonathan M.
    Doyle, Karen
    Naess, Halvor
    Putaala, Jukka
    Jood, Katarina
    Tatlisumak, Turgut
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
  • [10] Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 Patients
    DeFelipe-Mimbrera, Alicia
    Canovas, Araceli Alonso
    Guillan, Marta
    Matute, Consuelo
    de la Maza, Susana Sainz
    Cruz, Antonio
    Vera, Rocio
    Masjuan, Jaime
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
12345